152 related articles for article (PubMed ID: 16464638)
1. Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure.
Chong KS; Gardner RS; Morton JJ; Ashley EA; McDonagh TA
Eur J Heart Fail; 2006 Jun; 8(4):355-60. PubMed ID: 16464638
[TBL] [Abstract][Full Text] [Related]
2. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential.
Japp AG; Newby DE
Biochem Pharmacol; 2008 May; 75(10):1882-92. PubMed ID: 18272138
[TBL] [Abstract][Full Text] [Related]
3. Apelin: a new plasma marker of cardiopulmonary disease.
Goetze JP; Rehfeld JF; Carlsen J; Videbaek R; Andersen CB; Boesgaard S; Friis-Hansen L
Regul Pept; 2006 Jan; 133(1-3):134-8. PubMed ID: 16263185
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin.
Francia P; Salvati A; Balla C; De Paolis P; Pagannone E; Borro M; Gentile G; Simmaco M; De Biase L; Volpe M
Eur J Heart Fail; 2007 Mar; 9(3):306-9. PubMed ID: 16891152
[TBL] [Abstract][Full Text] [Related]
5. Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy.
Miettinen KH; Magga J; Vuolteenaho O; Vanninen EJ; Punnonen KR; Ylitalo K; Tuomainen P; Peuhkurinen KJ
Regul Pept; 2007 May; 140(3):178-84. PubMed ID: 17223209
[TBL] [Abstract][Full Text] [Related]
6. Myocardial apelin production is reduced in humans with left ventricular systolic dysfunction.
Chandrasekaran B; Kalra PR; Donovan J; Hooper J; Clague JR; McDonagh TA
J Card Fail; 2010 Jul; 16(7):556-61. PubMed ID: 20610231
[TBL] [Abstract][Full Text] [Related]
7. Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target.
Falcão-Pires I; Leite-Moreira AF
Rev Port Cardiol; 2005 Oct; 24(10):1263-76. PubMed ID: 16398242
[TBL] [Abstract][Full Text] [Related]
8. Increased apelin following bone marrow mononuclear cell transplantation contributes to the improvement of cardiac function in patients with severe heart failure.
Gao LR; Xu RY; Zhang NK; Chen Y; Wang ZG; Zhu ZM; Fei YX; Cao Y; Xu HT; Yang Y
Cell Transplant; 2009; 18(12):1311-8. PubMed ID: 19785937
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
Kleinz MJ; Skepper JN; Davenport AP
Regul Pept; 2005 Mar; 126(3):233-40. PubMed ID: 15664671
[TBL] [Abstract][Full Text] [Related]
10. Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus.
Telejko B; Kuzmicki M; Wawrusiewicz-Kurylonek N; Szamatowicz J; Nikolajuk A; Zonenberg A; Zwierz-Gugala D; Jelski W; Laudański P; Wilczynski J; Kretowski A; Gorska M
Diabetes Res Clin Pract; 2010 Feb; 87(2):176-83. PubMed ID: 19926159
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of the apelin system in cardiovascular homeostasis.
Chong KS; Gardner RS; Ashley EA; Dargie HJ; McDonagh TA
Biomark Med; 2007 Jun; 1(1):37-43. PubMed ID: 20477459
[TBL] [Abstract][Full Text] [Related]
12. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways.
Cui RR; Mao DA; Yi L; Wang C; Zhang XX; Xie H; Wu XP; Liao XB; Zhou H; Meng JC; Yuan LQ; Liao EY
Amino Acids; 2010 Nov; 39(5):1193-200. PubMed ID: 20495838
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells.
Kleinz MJ; Davenport AP
Regul Pept; 2004 May; 118(3):119-25. PubMed ID: 15003827
[TBL] [Abstract][Full Text] [Related]
14. The role of apelin in cardiovascular function and heart failure.
Chandrasekaran B; Dar O; McDonagh T
Eur J Heart Fail; 2008 Aug; 10(8):725-32. PubMed ID: 18583184
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of apelin in biology and medicine.
Kleinz MJ; Davenport AP
Pharmacol Ther; 2005 Aug; 107(2):198-211. PubMed ID: 15907343
[TBL] [Abstract][Full Text] [Related]
16. Apelin in acute myocardial infarction and heart failure induced by ischemia.
Tycinska AM; Lisowska A; Musial WJ; Sobkowicz B
Clin Chim Acta; 2012 Feb; 413(3-4):406-10. PubMed ID: 22146598
[TBL] [Abstract][Full Text] [Related]
17. Plasma apelin and asymmetric dimethylarginine levels in type 2 diabetic patients with diabetic retinopathy.
Yonem A; Duran C; Unal M; Ipcioglu OM; Ozcan O
Diabetes Res Clin Pract; 2009 Jun; 84(3):219-23. PubMed ID: 19344973
[TBL] [Abstract][Full Text] [Related]
18. The 212A variant of the APJ receptor gene for the endogenous inotrope apelin is associated with slower heart failure progression in idiopathic dilated cardiomyopathy.
Sarzani R; Forleo C; Pietrucci F; Capestro A; Soura E; Guida P; Sorrentino S; Iacoviello M; Romito R; Dessì-Fulgheri P; Pitzalis M; Rappelli A
J Card Fail; 2007 Sep; 13(7):521-9. PubMed ID: 17826642
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia.
Esposito V; De Falco M; De Luca L; Acanfora F; Onori N; Loiacono L; Montesarchio V; Rossi M; De Luca B; Chirianni A
In Vivo; 2002; 16(5):337-40. PubMed ID: 12494874
[TBL] [Abstract][Full Text] [Related]
20. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.
Chen MM; Ashley EA; Deng DX; Tsalenko A; Deng A; Tabibiazar R; Ben-Dor A; Fenster B; Yang E; King JY; Fowler M; Robbins R; Johnson FL; Bruhn L; McDonagh T; Dargie H; Yakhini Z; Tsao PS; Quertermous T
Circulation; 2003 Sep; 108(12):1432-9. PubMed ID: 12963638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
